Clinical trial
A Trial of Active Psoriatic Arthritis (PsA): Randomizing to Treat to a Target vs. Usual Care
NCT01692912 is registered in ClinicalTrials.gov with Pope Research Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Trial of Active Psoriatic Arthritis (PsA): Randomizing to Treat to a Target vs. Usual Care
- Lead sponsor
- Pope Research Corporation
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- October 31, 2012
- Completion date
- November 30, 2014
- Enrollment
- 0 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
psoriatic arthritis (psa)